KIR3DL1 and acute myeloid leukemia: The authors showed in their studies that the KIR/HLA mismatch of the donor-recipient after the removal of T cells from the graft material in patients with (acute myeloid leukemia) AML after transplantation contributed to a significantly lower rate of relapses.